KELLY FURUIKE: Open Payments
NPI 1386019388 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,654 in 46 payments from 20 companies in 2025. Trend: 2023 $718 · 2024 $2,128 · 2025 $1,654
Food & beverage: $1,654
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 7 | $514 |
| Insmed, Inc. | 1 | $134 |
| GENZYME CORPORATION | 1 | $126 |
| Alexion Pharmaceuticals, Inc. | 4 | $118 |
| PFIZER INC. | 5 | $109 |
| ABBVIE INC. | 5 | $95 |
| TG Therapeutics, Inc. | 2 | $84 |
| Teva Pharmaceuticals USA, Inc. | 4 | $76 |
| Cycle Pharmaceuticals Inc | 3 | $75 |
| Vanda Pharmaceuticals Inc. | 2 | $61 |
Products named: WATCHMAN, WATCHMAN FLX, Arikayce, DUPIXENT, ULTOMIRIS, NURTEC ODT, General - DBS, BRIUMVI.
Industry payments across HI — which companies pay providers there.
